Skip to main content
letter
. 2020 Aug 3;34(12):e803–e805. doi: 10.1111/jdv.16648

Figure 1.

Figure 1

Distribution of PASIh scores of patients with baseline PASIh scores ≥ 1.4 at (a) week 12 and (b) week 28. Median baseline PASIh score was 1.4 for TIL 100 mg and 1.2 for PBO. TIL 100 mg, n = 163; PBO, n = 72. a n = 1. PBO‐randomized patients received PBO to week 12, followed by TIL 100 or 200 mg to week 28. PASIh, Psoriasis Area and Severity Index head component; PBO, placebo; TIL, tildrakizumab.